A Clinical Trial to Assess the Effectiveness of NRF2 Activator (Oral Sodium-copper- Chlophyllin ) in Locally Advanced Cervical Cancer to Reduce Late Radiotherapy Toxicity.

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

316

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

March 31, 2030

Study Completion Date

September 30, 2030

Conditions

Uterine Cervical Neoplasm

Interventions

DIETARY_SUPPLEMENT

Sodium-copper-chlorophyllin, a semi-synthetic derivative of chlorophyll, is made up of a mixture of sodium copper salts.

Oral adjuvant sodium-copper-chlorophyllin 750mg given once daily given on an empty stomach for 3 months, starting within 2 weeks of RT completion

All Listed Sponsors

lead

Tata Memorial Hospital

OTHER_GOV